AI assistant
Sarama Resources Ltd. — Interim / Quarterly Report 2026
May 14, 2026
46917_rns_2026-05-14_4e83142c-fc0c-4659-b63b-ab23e9a8b5d9.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
Sarama Resources Ltd
(An Exploration Stage Company)
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
For the three months ended March 31, 2026
(Unaudited)
(Expressed in United States Dollars)
MANAGEMENT'S RESPONSIBILITY FOR FINANCIAL INFORMATION
The accompanying condensed interim consolidated financial statements and all other financial information included in this report are the responsibility of management. The condensed interim consolidated financial statements have been prepared in accordance with IFRS Accounting Standards ("IFRS"). Financial statements include certain amounts based on estimates and judgments. When alternative methods exist, management has chosen those it deems most appropriate in the circumstances to ensure that the condensed interim consolidated financial statements are presented fairly, in all material respects.
Management maintains appropriate systems of internal control, consistent with reasonable cost, to give reasonable assurance that its assets are safeguarded, and the financial records are properly maintained.
The Board of Directors is responsible for ensuring that management fulfils its responsibilities for financial reporting and internal control. The Audit Committee, which is comprised of three Directors, all of whom are non-management and independent, meets with management to review the consolidated financial statements to satisfy itself that management is properly discharging its responsibilities to the Directors, who approve the condensed interim consolidated financial statements.
Management recognizes its responsibility for conducting the Company's affairs in compliance with established financial reporting standards, and applicable laws and regulations, and for maintaining proper standards of conduct for its activities.
NOTICE OF NO AUDITOR REVIEW OF INTERIM FINANCIAL STATEMENTS
Under National Instruments 51-102, Part 4, subsection 4.3(3)(a), if an auditor has not performed a review of the interim financial statements, they must be accompanied by a notice indicating that the financial statements have not been reviewed by an auditor.
The accompanying unaudited condensed interim consolidated financial statements have been prepared by and are the responsibility of the Company's management. The Company's independent auditor has not performed a review of these financial statements in accordance with the standards established by the Canadian Institute of Chartered Accountants for a review of interim financial statements by an entity's auditor.
(signed) "Andrew Dinning"
Executive Chairman
May 15, 2026
(signed) "Lui Evangelista"
CFO
May 15, 2026
Sarama Resources Ltd
An Exploration Stage Company
Consolidated Statement of Financial Position
Expressed in United States Dollars
| Note | As at March 31, 2026 $ | As at December 31, 2025 $ | |
|---|---|---|---|
| ASSETS | |||
| Current assets | |||
| Cash and cash equivalents | 4 | 289,998 | 865,855 |
| Security deposits | 24,048 | 23,385 | |
| Other receivables | 26,101 | 25,661 | |
| Prepayments | 14,395 | 21,077 | |
| Total current assets | 354,542 | 935,978 | |
| Non-current assets | |||
| Plant and equipment | 5 | 4,987 | 5,633 |
| Total non-current assets | 4,987 | 5,633 | |
| Total assets | 359,529 | 941,611 | |
| LIABILITIES | |||
| Current liabilities | |||
| Accounts payable and accrued liabilities | 14 | 1,173,329 | 1,257,791 |
| Provision for employee entitlements | 211,217 | 204,976 | |
| Derivative liability | 7 | 391,124 | 487,128 |
| Total current liabilities | 1,775,670 | 1,949,895 | |
| Non-current liabilities | |||
| Provision for employee entitlements | 381 | 295 | |
| Total non-current liabilities | 381 | 295 | |
| Total liabilities | 1,776,051 | 1,950,190 | |
| DEFICIENCY | |||
| Share capital | 7(b) | 63,262,916 | 63,262,916 |
| Share-based payments reserve | 7(d) | 5,597,248 | 5,577,508 |
| Accumulated losses | (70,276,686) | (69,849,003) | |
| Total deficiency | (1,416,522) | (1,008,579) | |
| Total liabilities and deficiency | 359,529 | 941,611 |
Nature of operations and going concern (Note 1)
Arbitration proceeding (Note 15)
These consolidated financial statements are authorised for issue by the Board of Directors on May 15, 2026.
They are signed on the Company's behalf by
(Signed) "Andrew Dinning" Andrew Dinning, Director
(Signed) "Simon Jackson" Simon Jackson, Director
The accompanying notes are an integral part of these consolidated financial statements.
Sarama Resources Ltd
An Exploration Stage Company
Consolidated Statement of Loss and Comprehensive Loss
Expressed in United States Dollars
| Note | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| Income | ||
| Interest income | 5,034 | 9,697 |
| Total income | 5,034 | 9,697 |
| Expenses | ||
| Accounting and audit | 6,280 | 5,006 |
| Depreciation | 5 | 994 |
| Directors’ fees | 23,086 | 20,931 |
| Exploration expenditure as incurred | 3 | 419,515 |
| Fair value (gain) / loss on warrants carried at fair value through profit or loss | 7 | 10,256 |
| Finance charges | (96,004) | 10,256 |
| Foreign exchange (gain) / loss | 3,356 | 2,724 |
| Insurance | (27,993) | (811) |
| Marketing and investor relations | 5,881 | 9,598 |
| Office and general | 6,970 | 5,002 |
| Professional fees | 53,180 | 61,405 |
| Salaries | 44,286 | 60,826 |
| Stock-based compensation | 156,759 | 81,068 |
| Travel | 19,740 | - |
| Total expenses | 432,717 | 683,341 |
| Loss and comprehensive loss for the period | 427,683 | 673,644 |
| Basic and diluted loss per share | 12 | (0.1) cents |
| Weighted average number of shares | ||
| Basic and diluted | 463,070,521 | 355,087,844 |
The accompanying notes are an integral part of these consolidated financial statements.
4
Sarama Resources Ltd
An Exploration Stage Company
Consolidated Statement of Cash Flows
Expressed in United States Dollars
| Note | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| Cash flows from operating activities | ||
| Payments to suppliers and employees | (298,896) | (268,312) |
| Payments for exploration and evaluation | (309,685) | (435,762) |
| Interest received | 5,034 | 9,697 |
| Net cash used in operating activities | 13 | (603,547) |
| Cash flows from investing activities | ||
| Purchase of plant and equipment | 5 | - |
| Net cash from / (used in) investing activities | - | |
| Cash flows from financing activities | ||
| Payment of share issue costs | - | |
| Net cash from financing activities | - | |
| Net increase / (decrease) in cash and cash equivalents | (603,547) | |
| Net foreign exchange differences | 27,690 | 12,699 |
| Cash and cash equivalents at beginning of the period | 865,855 | 1,148,675 |
| Cash and cash equivalents at end of the period | 289,998 | 463,420 |
| Supplemental cash flow information (Note 13) |
The accompanying notes are an integral part of these consolidated financial statements.
5
Sarama Resources Ltd
An Exploration Stage Company
Consolidated Statement of Changes in Equity (Deficiency)
Expressed in United States Dollars
| Number of common shares | Share capital (Note 7) | Share-based payments reserve | Accumulated losses | Total | |
|---|---|---|---|---|---|
| $ | $ | $ | $ | ||
| Balance at December 31, 2024 | 347,937,815 | 61,513,987 | 5,322,513 | (67,069,499) | (232,999) |
| Loss and comprehensive loss for the year | - | - | - | (2,779,504) | (2,779,504) |
| Issue of shares (7(b)) | 115,132,706 | 2,260,883 | - | - | 2,260,883 |
| Fair value of share issue ascribed to warrants and recorded as derivative liability (7(b)) | - | (230,603) | - | - | (230,603) |
| Share issuance costs (7(b)) | - | (281,351) | - | - | (281,351) |
| Stock-based broker warrants | - | - | 152,398 | - | 152,398 |
| Stock-based compensation - options (7(d)(i)) | - | - | 102,597 | - | 102,597 |
| Balance at December 31, 2025 | 463,070,521 | 63,262,916 | 5,577,508 | (69,849,003) | (1,008,579) |
| Loss and comprehensive loss for the period | - | - | - | (427,683) | (427,683) |
| Issue of shares (7(b)) | - | - | - | - | - |
| Fair value of share issue ascribed to warrants and recorded as derivative liability (7(b)) | - | - | - | - | - |
| Share issuance costs (7(b)) | - | - | - | - | - |
| Stock-based broker warrants | - | - | - | - | - |
| Stock-based compensation - options (7(d)(i)) | - | - | 19,740 | - | 19,470 |
| Balance at March 31, 2026 | 463,070,521 | 63,262,916 | 5,597,248 | (70,276,686) | (1,416,522) |
The accompanying notes are an integral part of these consolidated financial statements.
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
1. NATURE OF OPERATIONS
Sarama Resources Ltd (the “Company” or “Sarama”) was incorporated on April 8, 2010, under the laws of the Province of British Columbia, Canada. The Company’s address is Unit 8, 245 Churchill Avenue, Subiaco, Western Australia, Australia 6008. The Company’s registered office address is Suite 2200, HSBC Building, 885 West Georgia Street, Vancouver BC, Canada, V6C 3E8. The Company is listed on the TSX Venture Exchange (“TSXV”) under the symbol “SWA” and on the Australian Securities Exchange (“ASX”) under the symbol “SRR”.
ASX uses an electronic system called CHESS for the clearance and settlement of trades on ASX. The Company is incorporated in British Columbia, Canada, and the requirements of British Columbia law are such that registered shareholders have the right to receive a stock certificate, with such requirement not permitting the CHESS system of holding uncertificated securities. Accordingly, to enable companies such as the Company to have their securities cleared and settled electronically through CHESS, depository instruments called CDIs are issued. CDIs represent the beneficial interest in the underlying shares in a foreign company such as the Company and are traded in a manner similar to shares of Australian companies listed on ASX. Each CDI is equivalent to one Share.
Statement of compliance
These condensed interim consolidated financial statements have been prepared in United States Dollars.
The board of directors of the Company have approved these condensed interim consolidated financial statements on May 15, 2026.
Business Activities
The consolidated entity, consisting of Sarama Resources Ltd. and its subsidiaries is in the exploration stage and its principal business activity is the sourcing and exploration of mineral properties. As at March 31, 2026, the Company is in the process of exploring its principal mineral properties and has not yet determined whether the properties contain gold reserves that are economically recoverable.
The condensed interim consolidated financial statements for the period ended March 31, 2026, comprise the accounts of Sarama Resources Ltd and its subsidiaries and the Company’s interest in equity accounted investments.
Basis of Presentation
These condensed interim consolidated financial statements have been prepared under the historical cost convention except for financial assets and liabilities at fair value through profit or loss and in accordance with IFRS Accounting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).
Going Concern
The condensed interim consolidated financial statements have been prepared on the going concern basis, which contemplates the continuity of normal business activities and the realisation of assets and discharge of liabilities in the normal course of business.
As disclosed in the condensed interim consolidated financial statements for the period ended March 31, 2026, the Company recorded a loss of $427,683 and had a net cash outflow from operating activities of $603,547. As at March 31, 2026, the Company had available cash of $289,998 and a deficit of current assets over current liabilities of $1,421,128.
The Directors have reviewed cashflow forecasts for the upcoming period and assessed that the Company will need to complete a capital raising or obtain alternative sources of financing to support forecast future cashflows over the relevant period of twelve months from the anticipated date of signing of these financial statements. A process is currently being conducted to determine the likely timing and quantum of these future sources of funding.
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
Should this capital raising or alternative source of financing not eventuate, or not eventuate on a sufficiently timely basis, there is a material uncertainty that may cast significant doubt as to whether the consolidated entity will continue as a going concern and realise its assets and extinguish its liabilities in the normal course of business and at the amounts stated in the financial report.
2. MATERIAL ACCOUNTING POLICIES
a) Standards and Interpretations applicable to March 31, 2026
In the period ended March 31, 2026, the Directors have reviewed all the new and revised Standards and Interpretations issued by the IASB that are relevant to the consolidated entity and effective for the current annual reporting period. As a result of this review, the Directors have determined that there is no material impact of the new and revised Standards and Interpretations on the Company and, therefore, no material change is necessary to the consolidated entity’s accounting policies.
b) Standards and Interpretations in issue not yet adopted
The Directors have also reviewed all the new and revised Standards and Interpretations in issue not yet adopted for the period ended March 31, 2026. As a result of this review the Directors have determined that there is no material impact of the Standards and Interpretations in issue not yet adopted on the consolidated entity and, therefore, no change is necessary to the consolidated entity’s accounting policies.
IFRS 18 – Presentation and Disclosure in Financial Statements
In April 2024, the IASB issued IFRS 18, Presentation and Disclosure of Financial Statements (IFRS 18), which replaces IAS 1, Presentation of Financial Statements. IFRS 18 introduces a specified structure for the income statement by requiring income and expenses to be presented into the three defined categories of operating, investing and financing, and by specifying certain defined totals and subtotals. Where company-specific measures related to the income statement are provided, IFRS 18 requires companies to disclose explanations around these measures, which are referred to as management defined performance measures. IFRS 18 also provides additional guidance on principles of aggregation and disaggregation which apply to the primary financial statements and the notes.
IFRS 18 will not affect the recognition and measurement of items in the financial statements, nor will it affect which items are classified in other comprehensive income and how these items are classified. The standard is effective for reporting periods beginning on or after January 1, 2027, including for interim financial statements. Retrospective application is required, and early application is permitted. The Company is currently assessing the effect of this new standard on its financial statements.
c) Basis of Consolidation
The condensed interim consolidated financial statements incorporate the assets and liabilities of the Company as at March 31, 2026 and the results of all subsidiaries for the period then ended.
Subsidiaries are all entities over which the Company has control (Note 10). The Company controls an entity when the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases.
Intercompany transactions, balances and unrealised gains on transactions are eliminated. Unrealised losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the Company.
d) Foreign Currency Translation
(a) Functional and Presentation Currency
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
Items included in the financial statements of each of the Company’s consolidated entities are measured using the currency of the primary economic environment in which the entity operates (“the functional currency”). The condensed interim consolidated financial statements are presented in United States dollars (“USD”), which is the Company’s functional and presentation currency.
(b) Transactions and Balances
Monetary assets and liabilities of the Company are translated into USD at the exchange rate in effect at balance date while non-monetary assets and liabilities, revenues and expenses are translated using exchange rates in effect at the time of each transaction. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss.
All foreign exchange gains and losses are presented separately in profit or loss for the financial period.
Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair-value was determined. Translation differences on assets and liabilities carried at fair value are reported as part of the fair value gain or loss.
(c) Functional Currency
The results and financial position of foreign operations that have a functional currency different from the presentation currency are translated into the presentation currency as follows:
- assets and liabilities for each statement of financial position presented are translated at the closing rate at the balance date,
- income and expenses for each statement of profit or loss and other comprehensive income are translated at average exchange rates (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case, income and expenses are translated at the dates of the transactions), and
- all resulting exchange differences are recognised in other comprehensive income.
e) Financial Instruments
Cash and cash equivalents are classified as current assets and include short-term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant risk of change in value. The Company places the majority of its cash holdings with an Australian financial institution which has a high credit rating.
Non-derivative financial assets and liabilities
The Company has the following non-derivative financial assets and liabilities:
i. Receivables
Receivables are financial assets with fixed or determinable payments that are not quoted in an active market. Such assets are initially recognised at fair value, less any directly attributable transaction costs. Subsequent to initial recognition, receivables are measured at amortised cost using the effective interest method, less any impairment losses.
ii. Financial assets at fair value through profit or loss (FVTPL)
Financial assets that are held within a different business model other than ‘hold to collect’ or ‘hold to collect and sell’ are categorised at fair value through profit or loss. Further, irrespective of the business model, financial assets whose contractual cash flows are not solely payments of principal and interest are accounted for at FVTPL. Assets in this category are measured at fair value with gains or losses recognised in profit or loss. The fair values of financial assets in this category are determined by reference to active market transactions or using a valuation technique where no active market exists.
iii. Amounts payable and other accrued liabilities
9
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
Such financial liabilities are recognised initially at fair value, net of any directly attributable transaction costs. Subsequent to initial recognition, these financial liabilities are measured at amortised cost using the effective interest method if significant.
f) Exploration and Evaluation Assets
Mineral exploration, evaluation, and acquisition costs are expensed as incurred based upon each area of interest. Where a decision has been made to proceed with development in respect of a particular area of interest, all future costs are recorded as a development asset.
g) Impairment of Plant and Equipment
At the end of each reporting period, the carrying amounts of the Company’s plant and equipment are reviewed to determine whether there is any indication that those assets are impaired. If any such indication exists, the recoverable amount of these assets is estimated in order to determine the extent of the impairment, if any. The recoverable amount is determined as the higher of the fair value less costs to sell for the asset and the asset’s value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time-value-of-money and the risks specific to the asset. If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount and the impairment loss is recognised within profit or loss for the period. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash generating unit to which the asset belongs.
Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but to an amount that does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss.
h) Plant and Equipment
The cost of all plant and equipment is stated at historical cost less depreciation and impairment charges. Historical cost includes expenditure that is directly attributable to the acquisition of the items. Assets are depreciated over their estimated useful service lives using the straight-line method as follows:
| Office equipment | 4 years |
|---|---|
| Plant and equipment | 3 years |
| Motor vehicles | 4 years |
i) Stock-based Compensation
The fair value of share purchase options or warrants granted is determined by the Black-Scholes option pricing model using estimates for the volatility of the trading price of the Company’s stock, the expected lives of share purchase options awarded, the fair value of the Company’s shares and the risk-free interest rate.
For employees, the fair value of the options is measured at the date of the grant. For non-employees, the fair value of the options is measured on the earlier of the date on which the counterparty performance is complete or the date the performance commitment is reached or the date at which the equity instruments are granted if they are fully vested and non-forfeitable. The estimated fair value of awards of share purchase options is charged to expense over the vesting period, with offsetting amounts to equity. If the share purchase options are granted for past services, they are expensed immediately. If the share purchase options are forfeited prior to vesting, no amounts are charged to expense. If share purchase options are exercised, then the fair value of the options is re-classed from stock-based compensation reserve to share capital.
At each reporting date, the amount recognised as an expense is adjusted to reflect the actual number of share purchase options or warrants that are expected to vest. The corresponding entry is recognised in the stock-based compensation reserve.
10
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
j) Basic and Diluted Earnings/Loss per Share
The Company presents basic and diluted earnings/loss per share data for its common shares, calculated by dividing the result attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted earnings per share does not adjust the profit or loss attributable to common shareholders or the weighted average number of common shares outstanding when the effect is anti-dilutive.
k) Share Warrants
In accordance with IFRS, an obligation to issue shares for a price that is not fixed in the Company’s functional currency, and that does not qualify as a rights offering, must be classified as a derivative liability and measured at fair value through profit or loss in accordance with the requirements of IAS 32 Financial Instruments: Presentation. The financial liability will be accounted for at fair value through profit or loss until such time that the warrants are exercised or lapse, at which point the liability will be transferred to equity.
l) Income Taxes
Income tax on the profit or loss for the period presented comprises current and deferred tax. Income tax is recognised in profit or loss except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity.
Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at year end, adjusted for amendments to tax payable with regards to previous years.
Deferred tax is provided for temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The following temporary differences are not provided for: goodwill not deductible for tax purposes; the initial recognition of assets or liabilities that affect neither accounting nor taxable profit; and differences relating to investments in subsidiaries, associates, and joint ventures to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realisation or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the reporting date applicable to the period of expected realisation or settlement.
A deferred tax asset is recognised only to the extent that it is probable that future taxable profits will be available against which the asset can be utilised.
m) Segment Reporting
Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker is responsible for allocating resources and assessing performance of the operating segments. Refer to note 13 for further information.
n) Critical Estimates and Judgements
The preparation of financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Estimates and assumptions are continually evaluated and are based on management experience and other factors, including expectations about future events that are believed to be reasonable under the circumstances. However, actual outcomes can differ from these estimates. Information about significant areas of estimation uncertainty considered by management in preparing the financial statements is described below.
Measurement of warrants and stock options
The Company determines the fair value of both warrants and options classified as liabilities at fair value through profit or loss using the Black-Scholes Model. Note 7 provides detailed information about the key assumptions used in the determination of the fair value of options and warrants.
11
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
3. EXPLORATION
| Cosmo Project, Western Australia, Australia | Mt Venn Project, Western Australia, Australia | NSW Project, New South Wales, Australia | Sanutura Project Burkina Faso | Total | |
|---|---|---|---|---|---|
| 2026 March Quarter | |||||
| Geochemistry | 416 | 1,170 | - | - | 1,586 |
| Geological | 22,111 | 13,673 | - | - | 35,784 |
| Geophysical | - | 4,695 | - | - | 4,695 |
| Native Title | 68,642 | 4,717 | - | - | 73,359 |
| Government fees | 42,811 | 36,125 | 5.173 | - | 84,109 |
| Administration | - | - | 3,795 | 33,268 | 37,063 |
| Expenditure incurred during the period | 133,980 | 60,380 | 8,968 | 33,268 | 236,596 |
| 2025 March Quarter | |||||
| --- | --- | --- | --- | --- | --- |
| Acquisition | - | 12,306 | - | - | 12,306 |
| Camp | 2,167 | 3,398 | - | - | 5,565 |
| Geochemistry | 210,820 | 13,286 | - | - | 224,106 |
| Geological | 70,452 | 13,227 | - | - | 83,679 |
| Native Title | 4,063 | - | - | - | 4,063 |
| Government fees | 27,266 | 24,863 | - | - | 52,129 |
| Administration | - | - | - | 37,667 | 37,667 |
| Expenditure incurred during the period | 314,768 | 67,080 | - | 37,667 | 419,515 |
NSW Project
In 2026 the Company was granted tenure to three exploration licences covering a portfolio of early-stage copper-gold properties in New South Wales, targeting underexplored areas within and adjacent to the Lachlan Fold Belt that are prospective for copper, gold and polymetallic mineralisation.
4. CASH AND CASH EQUIVALENTS
| | March 31, 2026
$ | December 31, 2025
$ |
| --- | --- | --- |
| Cash at bank and in hand | 98,857 | 111,831 |
| Deposits at call | 191 141 | 754,024 |
| | 289 998 | 865,855 |
Cash at bank earns interest at floating rates based on daily bank deposit rates. Short-term deposits are made on a rolling overnight basis and earn interest at the respective short-term deposit rates.
The Company’s exposure to interest rate risk and sensitivity analysis for financial assets and liabilities is disclosed in Note 8.
12
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
5. PLANT AND EQUIPMENT
March 31, 2026
| Plant and Equipment $ | Motor Vehicles $ | Office Equipment $ | Total $ | |
|---|---|---|---|---|
| Opening net book value | 208 | - | 5,425 | 5,633 |
| Additions | - | - | - | - |
| Depreciation | (40) | - | (605) | (645) |
| Closing net book value | 168 | - | 4,820 | 4,988 |
| Cost | 109,612 | 28,922 | 253,158 | 391,692 |
| Accumulated Depreciation | (109,444) | (28,922) | (248,338) | (386,704) |
| Closing net book value | 168 | - | 4,820 | 4,988 |
Depreciation is allocated within the statement of loss as follows.
Depreciation: $580 (2025: $994)
Exploration expenditure as incurred: $65 (2025: $3,974)
December 31, 2025
| Plant and Equipment $ | Motor Vehicles $ | Office Equipment $ | Total $ | |
|---|---|---|---|---|
| Opening net book value | 6,140 | 4,020 | 3,037 | 13,197 |
| Additions | - | - | 5,667 | 5,667 |
| Depreciation | (5,932) | (4,020) | (3,279) | (13,231) |
| Closing net book value | 208 | - | 5,425 | 5,633 |
| Cost | 109,612 | 28,922 | 253,158 | 391,692 |
| Accumulated Depreciation | (109,404) | (28,922) | (247,733) | (386,059) |
| Closing net book value | 208 | - | 5,425 | 5,633 |
6. INVESTMENT IN ASSOCIATE
The Company has determined that it has significant influence over Joint Venture BFI Inc., a joint venture focussed on the exploration and evaluation of the Karankasso Project ("the Project") in Burkina Faso, as it holds 17.45% (2025: 17.45%) of the voting power as well as holding 2 out of the 4 Board positions. The Company's interest is accounted for using the equity method in the consolidated financial statements. Summarised financial information of the joint venture, based on IFRS financial statements, and a reconciliation with the carrying amount of the investment in the condensed interim consolidated financial statements are set out below. The Company has not made any additional contributions during the period ended March 31, 2026.
13
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
Summarised statement of financial position of Joint Venture BF1 Inc.:
| | March 31, 2026
$ | December 31, 2025
$ |
| --- | --- | --- |
| Current assets | 214,086 | 301,970 |
| Non-current assets | - | - |
| Current liabilities | (156,753) | (75,058) |
| Non-current liabilities | (5,632,412) | (5,632,412) |
| Equity | (5,575,079) | (5,405,500) |
| Reconciliation to carrying amount of investment | | |
| Company’s share of equity | (972,851) | (943,260) |
| Plus additional contributions | 1,365,851 | 1,365,851 |
| | 393,000 | 422,591 |
| Notional premium on acquisition by JV | (393,000) | (422,591) |
| Karankasso Project Joint Venture– at cost | - | - |
| Reconciliation of carrying amount of investment | March 31, 2026
$ | December 31, 2025
$ |
| Opening carrying amount | 1,836,171 | 1,836,171 |
| Share of loss after tax | (1,836,171) | (1,836,171) |
| Closing carrying amount | - | - |
As the share of equity associated losses exceeds the Company’s interest in the investee, the investment has been written down to nil.
7. SHARE CAPITAL
(a) Authorised Share Capital
At March 31, 2026, the authorised share capital comprised an unlimited number of common shares without par value.
(b) Issued Share Capital
| Details | 2026
Number of
shares | 2026
$ | 2025
Number of
shares | 2025
$ |
| --- | --- | --- | --- | --- |
| | | | | |
| Balance at January 1 | 463,070,521 | 63,262,916 | 347,937,815 | 61,513,987 |
| Issue of shares for debt (i) | - | - | 13,132,706 | 247,173 |
| Share issuance costs | - | - | - | (2,184) |
| Balance at March 31 (net of costs) | 463,070,521 | 63,262,916 | 361,070,521 | 61,758,976 |
| Issue of shares under private placement (ii) | | | 90,000,000 | 1,763,440 |
| Issue of shares for acquisition of exploration projects (iii) | | | 12,000,000 | 250,270 |
| Share issuance costs | | | - | (279,167) |
| Fair value warrants issued | | | - | (230,603) |
| Balance December 31 (net of costs) | | | 463,070,521 | 63,262,916 |
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
(i) Shares for Debt – February 2025
On February 10, 2025, the Company completed the issue of shares in part settlement of deferred executive salaries and director fees (the “Shares for Debt”). The Shares for Debt arrangement comprised the issue of 13,132,706 CDIs at a fair value of A$0.03 per CDI, equivalent to A$393,981 (US$247,173).
(ii) Private Placement July 2025 – Oct 2025
On July 8, 2025, the Company closed Tranche 1 of its private placement (the “Placement”) raising proceeds of A$2.6m by issuing 86,666,667 CDIs at an issue price of A$0.03 per CDI. Tranche 2 (“Tranche 2”) of the Placement consisted of 30,000,000 free attaching unlisted options (each a “Placement Option”) and 19,166,666 broker options (each a “Broker Option” and together with the Placement Options, the “Options”), with each Option exercisable at A$0.09 and expiring on 30 November 2028. Tranche 2 of the Placement consisted of 3,333,333 CDIs and 1,111,111 attaching options (which are included in the total number of Placement Options specified above) to a director, Mr Andrew Dinning (“Director CDIs”). The Broker Options and 28,888,889 Placement Options were issued on October 7, 2025. The CDIs and options issued to Mr Dinning were issued on October 21, 2025. Funds received from Tranche 2 was A$100,000.
(iii) Shares for Acquisition of Mt Venn Gold Project – July 2025
On July 22, 2025 the Company completed the acquisition of a majority interest in the Mt Venn Project (the “Project”) in Western Australia with the Company issuing 12,000,000 CDIs at a fair value of A$0.032 per security, for consideration of A$384,000 (US$250,270) (Note 4).
(c) Warrants
Warrant transactions are summarized as follows:
| Number of Warrants | Weighted Average Exercise Price (A$) | |
|---|---|---|
| Balance – December 31, 2024 | 20,000,000 | 0.13 |
| Issued | 79,833,332 | 0.09 |
| Expired | (2,500,000) | 0.27 |
| Balance – December 31, 2025 | 97,333,332 | 0.09 |
| Issued | - | - |
| Expired | - | - |
| Balance – March 31, 2026 | 97,333,332 | 0.09 |
The Company has issued warrants as part of its capital raising and exploration programs. The details of all warrants still on issue are detailed below.
15
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
| Warrant issue | Total Warrants Issued | Exercise Price (A$) | Estimated fair value of warrants (A$) | Estimated fair value per warrant (A$) | Expiry Date |
|---|---|---|---|---|---|
| Acquisition Warrants issued | |||||
| December 5, 2024 (e) | 7,500,000 | 0.05 | 42,269 | 0.005 | December 5, 2026 |
| Broker Warrants issued | |||||
| February 10, 2025 (c) | 14,000,000 | 0.09 | 71,625 | 0.005 | November 30, 2028 |
| October 7, 2025 (a) | 19,166,666 | 0.09 | 233,446 | 0.012 | November 30, 2028 |
| Sub Total | 40,666,666 | 347,340 | 0.009 | ||
| Shareholder Warrants issued | |||||
| April 13, 2023 | 6,875,000 | 0.15 | 327,460 | 0.048 | April 13, 2026 |
| June 14, 2023 | 1,312,180 | 0.15 | 30,368 | 0.023 | June 14, 2026 |
| June 21, 2023 | 1,812,820 | 0.15 | 35,236 | 0.019 | June 21, 2026 |
| February 10, 2025 (d) | 16,666,666 | 0.09 | 85,268 | 0.005 | November 30, 2028 |
| October 7, 2025 (b) | 28,888,889 | 0.09 | 340,158 | 0.003 | November 30, 2028 |
| October 21, 2025 (b) | 1,111,111 | 0.09 | 13,083 | 0.003 | November 30, 2028 |
| Sub Total | 56,666,666 | 831,573 | 0.015 | ||
| Total Warrants | 97,333,332 | 1,178,193 | 0.012 |
a) 19,166,666 broker warrants were issued on October 7, 2025, to a broker assisting a private placement conducted by the Company in July 2025, at an exercise price of A$0.09 each and expire on November 30, 2028. The warrants were issued at a fair value of US$152,398 (A$233,446)
b) A total of 30,000,000 shareholder warrants were issued with 28,888,889 being issued on October 7, 2025 and 1,111,111 being issued on 21 October 2025, in relation to a private placement conducted by the Company in July 2025. The warrants are exercisable at A$0.09 and expire on November 30, 2028. The warrants were issued at a fair value of US$230,603 (A$353,241)
c) 14,000,000 broker warrants were issued on February 10, 2025, to brokers assisting a private placement conducted by the Company in November 2024, at an exercise price of A$0.09 each and expire on November 30, 2028. As the service to which the warrants related was completed at the time of the placement, the value of the warrants has been recorded in the prior year. The warrants were issued at a fair value of US$46,641 (A$71,625)
d) 16,666,666 shareholder warrants were issued on February 10, 2025, in relation to a private placement conducted by the Company in November 2024. The warrants are exercisable at A$0.09 and expire on November 30, 2028. As the warrants were promised during the placement to shareholders, the value of the warrants has been recorded in the year ended December 31, 2024. The warrants were issued at a fair value of US$55,525 (A$85,268)
e) 7,500,000 acquisition warrants were issued to Adelong Gold Limited, as directed by Cosmo Gold Limited (“Cosmo”), on December 5, 2024, as part consideration of definitive agreement executed by the Company and Cosmo on August 13, 2024, for the acquisition of an initial 80% interest in the Cosmo
16
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
Gold project in Western Australia. The warrants were issued at an exercise price of A$0.05 expiring on December 5, 2026, at a fair value of $27,216 (A$42,269).
The fair value of the acquisition warrants are recognised within the share-based payments reserve, within the equity section of the financial statements, in accordance with IFRS 2.
The fair value of shareholder warrants are recognised as a derivative liability in the financial statements in accordance with IAS 32. As the exercise price of the warrants is denominated in Australian dollars ("AUD"), which is different from the Company's functional currency (United States dollars ("USD"), the warrants do not meet the "fixed-for-fixed" criteria under IAS 32, Financial Instruments: Presentation. Consequently, the warrants are classified as a derivative financial liability.
The derivative liability was initially measured at its fair value on the date of issuance and is subsequently re-measured at each reporting date. Unrealized gains and losses arising from the re-measurement are recognized in the consolidated statement of loss and comprehensive loss.
The following table illustrates the changes in the derivative liability for the year:
| Number of Warrants issued in CAD | Number of Warrants issued in AUD | Carrying amount in USD | |
|---|---|---|---|
| Balance – December 31, 2024 | - | 26,666,666 | 49,379 |
| Warrants Issued | 30,000,000 | 230,603 | |
| Warrants Expired | - | - | - |
| Changes in fair value of derivative liability | - | - | 207,146 |
| Balance – December 31, 2025 | - | 56,666,666 | 487,128 |
| Warrants Issued | - | - | |
| Warrants Expired | - | - | - |
| Changes in fair value of derivative liability | - | - | (96,004) |
| Balance – March 31, 2026 | - | 56,666,666 | 391,124 |
The fair value of the derivative warrant liability as at March 31, 2026, and at issuance was estimated using the Black-Scholes option pricing model with the following weighted average assumptions:
| March 31, 2026 | At issuance | |
|---|---|---|
| Risk-free interest rate | 4.56% | 2.92 - 4.22% |
| Volatility | 81% | 46 - 64% |
| Expected life | 0.2 to 2.7 years | 3 to 4 years |
| Expected dividend yield | 0% | 0% |
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
The fair value of the warrants recognised in the financial statements has been estimated using the Black-Scholes Option-Pricing Model at inception with the following assumptions:
| Warrant issue | Price of Security on issue date | Risk – free interest rate | Expected dividend yield | Expected stock price volatility | Remaining warrant life |
|---|---|---|---|---|---|
| Broker Warrants issued October 7, 2025 | A$0.03 | 2.92% | 0% | 85% | 32 months |
| Shareholder Warrants issued October 7, 2025, and October 21, 2025 | A$0.03 | 2.92% | 0% | 85% | 32 months |
| Broker Warrants issued February 10, 2025 | A$0.03 | 2.98% | 0% | 54% | 32 months |
| Shareholder Warrants issued February 10, 2025 | A$0.03 | 2.98% | 0% | 54% | 32 months |
| Acquisition Warrants issued December 5, 2024 | A$0.03 | 3.03% | 0% | 55% | 8 months |
| Shareholder Warrants issued June 21, 2023 | A$0.08 | 4.22% | 0% | 62% | 3 months |
| Shareholder Warrants issued June 14, 2023 | A$0.08 | 4.15% | 0% | 61% | 3 months |
| Shareholder Warrants issued April 13,2023 | A$0.12 | 3.59% | 0% | 64% | 1 months |
(d) Company Stock Option Plan
The Company has a stock option plan (the "Plan") that provides for the issuance of up to 10% of the issued and outstanding shares of the Company. The board of directors is authorised to set the exercise price, expiry date, and vesting provisions for each grant, subject to the policies of the TSX Venture Exchange. The plan provides for a maximum grant period of ten years. Options can be exercised at any time prior to their expiry date.
Stock option transactions are summarized as follows:
| Number of Options | Weighted Average Exercise Price (A$) | |
|---|---|---|
| Balance – December 31, 2024 | 19,431,664 | 0.10 |
| Granted | 4,550,000 | 0.04 |
| Expired | (2,721,665) | 0.22 |
| Balance – December 31, 2025 | 21,259,999 | 0.07 |
| Granted | - | - |
| Expired | - | - |
| Balance – March 31, 2026 | 21,259,999 | 0.07 |
As at March 31, 2026 the following stock options were outstanding and exercisable:
| Grant Date | No. | Exercise Price | Expiry Date |
|---|---|---|---|
| April 20, 2023 (fully vested) | 6,809,999 | A$0.16 | April 20, 2026 |
| July 23, 2024 (fully vested) | 9,900,000 | A$0.03 | July 23, 2027 |
| April 2, 2025 (fully vested) | 4,550,000 | A$0.04 | April 2, 2028 |
| 21,259,999 |
No options were granted in the period ended March 31, 2026 (period ended March 31, 2025: Nil).
No options were exercised in the period ended March 31, 2026 (December 31, 2024: Nil).
(e) Equity Incentive Plan
The Company has an equity incentive plan that provides for the issuance of equity incentives, together with any other security-based compensation arrangements, of up to 10% of the issued and outstanding shares at any time. The Board of directors is authorised to determine which directors, officers, employees or consultants are eligible
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
to receive equity incentives ('Awards') under the Equity Incentive Plan; determine conditions under which Awards be granted, vested or exercised, including the expiry date, exercise price and vesting schedule of the Equity Incentives, and determine the number of Shares to be covered by any Award.
Details are as follows:
| Grant Date | Restricted Share Units (“RSUs”) | Performance Share Units (“PSUs”) | ||
|---|---|---|---|---|
| Outstanding | Vested | Outstanding | Vested | |
| April 11, 2025 | 2,310,000 | - | 9,240,000 | - |
The Awards are subject to the following vesting conditions:
| Vesting Condition | Expiry Date of Vesting Condition | Number of incentives |
|---|---|---|
| No lost time injuries at any of the Company’s projects | 11 April 2026 | 1,155,000 |
| 20 day VWAP reaches a minimum of A$0.06/share for a continuous period of 10 trading days | 11 April 2028 | 4,042,500 |
| Drill program returns 3 or more downhole intersection of a minimum of 20gm gold at the Cosmo Project or Mt Venn Project, with a minimum cut-off grade of 0.5 grams per tonne of gold and a minimum intercept length of 1 metre. | 11 April 2028 | 1,155,000 |
| The announcement of a Maiden Mineral Resource Estimate in accordance with the JORC Code of 200,000 ounces of gold at a 0.5g/t gold cut off of at least the Inferred category. | 11 April 2028 | 2,887,500 |
| Continuous service of 18 months from date of grant | 11 October 2026 | 2,310,000 |
RSUs
Each RSU is redeemable into one common share of the Company.
During the year ended December 31, 2025, the Company granted 2,310,000 RSUs at an average fair value of A$0.029 each to employees of the Company. The RSUs will vest upon continuous service eighteen months after the grant date.
During the period ended March 31, 2026, no (March 31, 2025 – nil) RSUs were redeemed for an equal number of common shares of the Company, and no (March 31, 2025 – nil) unvested RSUs were forfeited.
19
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
PSUs
Each PSU is redeemable into one common share of the Company.
During the year ended December 31, 2025, the Company granted 9,240,000 PSUs at an average fair value of A$0.027 each to employees of the Company. The PSUs will vest upon meeting certain conditions as follows;
- twelve months after the grant date (1,155,000 PSUs)
- within three years after the grant date (8,085,000 PSUs)
During the period ended March 31, 2026, no (March 31, 2025 – nil) PSUs were redeemed for an equal number of common shares of the Company, and no (March 31, 2025 – nil) unvested PSUs were forfeited.
(f) Stock-Based Compensation
The following table summarizes stock-based compensation expense by unit type:
| March 31, 2026 | March 31, 2025 | |
|---|---|---|
| $ | $ | |
| Stock Options | - | - |
| Restricted share units | 8,101 | - |
| Performance share units | 11,639 | - |
| Total stock-based compensation | 19,740 | - |
- FINANCIAL INSTRUMENTS
The Company is exposed to financial risks through the normal course of its business operations. The key risks impacting the Company's financial instruments are considered to be foreign currency risk, interest rate risk, liquidity risk, credit risk and equity price risk. The Company's financial instruments exposed to these risks are cash and short-term deposits, receivables, trade payables and investments in foreign operations.
The executive management team monitors the financial instrument risk to which it is exposed and assesses the impact and likelihood of those risks on an ongoing basis. Where material, these risks are reported and reviewed by the board of directors.
(a) Fair Values
The fair value of the Company's financial instruments approximates their carrying values due to the immediate or short-term maturity of these financial instruments. The Company's financial assets and liabilities are measured and recognised at fair value as at March 31, 2026 according to the following fair value measurement hierarchy:
(a) quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities (level 1),
(b) quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability (level 2), and
(c) prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity) (level 3).
(b) Financial Instrument Risk Exposure
Foreign currency risk
The Company has international operations in Australia, West Africa, namely Burkina Faso, and an administrative office in Western Australia. The multiple locations expose the Company to foreign exchange risk as detailed below:
- Canadian dollar (CAD) – primary source of Company funding and its corporate and regulatory costs.
- Australian dollar (AUD) – administrative costs in Western Australia.
- Euro and Communauté Financière Africaine Francs (CFA) – funding of African operations.
20
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
Management’s policy is to actively manage foreign exchange risk. Management mitigates foreign exchange risk by continuously monitoring forecasts and spot prices of foreign currency and holding foreign currency based on expected future expenditure commitments.
The carrying amounts of the Company’s financial assets and liabilities are denominated in USD, except as set out below:
As at March 31, 2026
| AUD $ | CAD $ | Euro € | |
|---|---|---|---|
| Cash and cash equivalents | 387,889 | 32,223 | 1,117 |
| Payables | 903,714 | 262,039 | 10,066 |
| As at December 31, 2025 | |||
| AUD $ | CAD $ | Euro € | |
| Cash and cash equivalents | 1,234,765 | 4,588 | 30,630 |
| Payables | 1,007,822 | 267,247 | 26,418 |
Sensitivity
Based on the financial instruments held as at March 31, 2026, had the US dollar weakened/strengthened by 10% against the AUD, CAD or Euro, with all other variables held constant, the Company’s losses/gains for the period would have been mainly as a result of foreign exchange gains/losses in translation of foreign denominated currencies. The following table summarises the sensitivity of the Company’s cash and cash equivalents to changes in foreign exchange rates.
The Company’s exposure to other foreign exchange movements is not material.
As at March 31, 2026
| AUD $ | CAD $ | Euro € | |
|---|---|---|---|
| USD Strengthened by 10% | 32,220 | 14,995 | 936 |
| USD Weakened by 10% | (39,379) | (18,328) | (1,144) |
| As at December 31, 2025 | |||
| AUD $ | CAD $ | Euro € | |
| USD Strengthened by 10% | (75,000) | (304) | (3,269) |
| USD Weakened by 10% | 91,667 | 372 | 3,995 |
Credit risk
Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents and accounts receivable.
The Company has reduced its credit risk by holding all of its cash and cash equivalents with an Australian financial institution, whose Moody’s Investor Service rating is Aa2, except for working capital requirements in West Africa.
Liquidity risk
Ultimate responsibility for liquidity risk rests with the Board of Directors, who oversee a liquidity risk management framework for the management of the Company’s funding and liquidity requirements.
21
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
The Company manages liquidity risk by continuously monitoring forecast and actual cash flows and ensuring there are adequate funds available to meet its operating and growth objectives. The Company relies on issuance of shares to fund exploration programs and will most likely issue additional shares in the future.
Interest rate risk
The Company is exposed to interest rate risk as entities in the Company deposit funds at both short-term fixed and floating rates of interest. Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate due to changes in market interest rates. Cash bears interest at variable rates. The fair value of cash approximates its carrying value due to the immediate or short-term maturity of this financial instrument.
Other current financial assets and liabilities are not exposed to interest rate risk because they are non-interest bearing.
Price risk
The Company is exposed to price risk with respect to commodity prices. Commodity price risk is defined as the potential adverse impact on earnings and economic value due to commodity price movements and volatilities. The Company closely monitors the commodity prices of precious metals and the stock market to determine the appropriate course of action to be taken by the Company.
9. CAPITAL MANAGEMENT
The Company's objectives when managing capital are to safeguard the Company's ability to continue as a going concern and to maintain a flexible capital structure which optimises the costs of capital at an acceptable risk.
The Company manages its capital structure and makes adjustments to it in accordance with the objectives stated above, as well as responding to changes in economic conditions and the risk characteristics of the underlying assets. There were no changes in the Company's approach to capital management during the period ended March 31, 2026. Management reviews its capital management approach on an ongoing basis and believes that this approach, given the relative size of the company, is reasonable. The Company is not subject to externally imposed capital requirements.
The properties in which the Company currently has interests are in the exploration stage. As such, the Company does not recognise revenue from its exploration properties. The Company's historical source of capital has consisted of the issue of equity securities, options and warrants. In order for the Company to carry out planned exploration and development and pay for administrative costs, the Company will spend its working capital and expects to raise additional amounts externally as needed.
The Company is exposed to various funding and market risks which could curtail its access to funds.
10. SUBSIDIARIES
The condensed interim consolidated financial statements incorporate the assets, liabilities and results of the following subsidiaries in accordance with the accounting policy described in Note 2:
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
| Name of entity | Country of Incorporation | Class of shares | Functional Currency | Equity holding % | |
|---|---|---|---|---|---|
| 2025 | 2024 | ||||
| Yikarri Resources Pty Ltd | Australia | Ordinary | USD | 100 | 100 |
| Sarama Investments Ltd | British Virgin Islands | Ordinary | USD | 100 | 100 |
| Sarama Investments (No.2) Limited | British Virgin Islands | Ordinary | USD | 100 | 100 |
| Sarama Investments Mali Limited | British Virgin Islands | Ordinary | USD | 100 | 100 |
| Vasto Mining Limited | British Virgin Islands | Ordinary | USD | 100 | 100 |
| SWA BF No.3 Investments Limited | British Virgin Islands | Ordinary | USD | 100 | 100 |
| Sarama Mining Burkina SUARL | Burkina Faso | Ordinary | USD | 100 | 100 |
| SWA SARL | Burkina Faso | Ordinary | USD | 100 | 100 |
| Eburnean Resources Limited – Burkina SARL | Burkina Faso | Ordinary | USD | 100 | 100 |
| Pedsam Mining Limited (Liberia) | Liberia | Ordinary | USD | 100 | 100 |
11. SEGMENT REPORTING
The Company consider the Board of Directors to be the chief operating decision maker.
The Company has one business segment, being the acquisition, exploration and potential development of mineral properties. The Company has operations in two geographic area, being Australia and Burkina Faso.
As at and for the period ended March 31, 2026
| Burkina Faso | Australia | Corporate | Total | |
|---|---|---|---|---|
| $ | $ | $ | $ | |
| Plant and equipment | 276 | - | 4,711 | 4,987 |
| As at and for the year ended December 31, 2025 | ||||
| Burkina Faso | Australia | Corporate | Total | |
| $ | $ | $ | $ | |
| Plant and equipment | 342 | - | 5,291 | 5,633 |
12. BASIC AND DILUTED LOSS PER SHARE
| Three months ended March 31, 2026 | Three months ended March 31, 2025 | |
|---|---|---|
| Cents per share | Cents per share | |
| Basic and diluted loss per share | (0.1) | (0.2) |
| $ | $ | |
| Net loss used in calculating basic/diluted loss per share | (427,683) | (673,644) |
| Weighted average number of shares on issue during the period used in the calculation of basic loss per share | 463,070,521 | 355,087,844 |
23
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
Diluted loss per share as at March 31, 2026 is the same as basic loss per share as it is unlikely that the warrants will be converted into common shares.
13. NOTES TO THE STATEMENT OF CASH FLOWS
Reconciliation of loss after tax to net cash flows from operations
| Three months ended March 31, 2026 $ | Three months ended March 31, 2025 $ | |
|---|---|---|
| Loss for the period | (427,683) | (673,644) |
| Depreciation | 646 | 4,968 |
| Fair value loss / (gain) on warrants carried at fair value through profit or loss | (96,004) | 10,256 |
| Stock–based compensation | 19,740 | - |
| Movements in provisions | 78 | 3,083 |
| Net exchange differences – (gain)/loss | (28,535) | 11,010 |
| Net cash outflows used in operating activities before change in working capital | (531,758) | (644,377) |
| Change in working capital | (71,789) | (50,049) |
| Net cash outflows used in operating activities | (603,547) | (694,377) |
14. ACCOUNTS PAYABLE & ACCRUED LIABILITIES
| March 31, 2026 $ | December 31, 2025 $ | |
|---|---|---|
| Accounts payable | 242,267 | 349,150 |
| Directors’ fees | 25,395 | 24,695 |
| Deferred salaries | 545,080 | 542,179 |
| Annual leave entitlements | 360,587 | 341,767 |
| 1,173,329 | 1,257,791 |
Deferred salaries and annual leave entitlement (together “employee entitlements”) relate to 3 key management personnel, and each have agreed a contract variation to their employment agreement whereby:
i) if an employment contract is terminated, the employee will not enforce immediate payment of their employee entitlements.
ii) the variation remains in place until January 1, 2027.
iii) in the event this employment agreement is terminated by either party prior to January 1, 2027, the employee agrees to convert any employee entitlements payable into an unsecured loan from the Company with interest accrued based on 90 day bank bill swap rate plus 8%.
iv) if the Company is subject to a change of Control event, the loan becomes due and payable immediately.
v) In the event a Change of Control event occurs this variation terminates immediately.
24
Sarama Resources Ltd
An Exploration Stage Company
Notes to the Consolidated Financial Statements
Expressed in United States Dollars unless otherwise stated
15. ARBITRATION PROCEEDINGS – LITIGATION FUNDING
In October 2024, the Company advised that it had entered into a Litigation Funding Agreement (“LFA”) with Locke Capital II LLC, an arm’s length party that specializes in providing funding for dispute resolution (the “Funder”) to commence international arbitration proceedings in relation to its investment dispute (the “Dispute”) with the Government of Burkina Faso. (refer announcement October 24, 2024)
The LFA provides a four-year non-recourse loan facility (“Facility”) of US$4.4 million to the Company to cover all fees and expenses related to its Claim to Arbitration (the “Claim”). If there is no settlement or award (or no default by Sarama under the LFA), the Company does not have an obligation to repay the loan. In the event of the occurrence of a material adverse change under the LFA, the Funder shall be entitled to recover only those funds which were advanced but remain unspent.
The Company has engaged Boies Schiller Flexner (UK) LLP (“BSF”), a leading international law firm, to assist with legal matters pertaining to the Dispute. The costs incurred by BSF are presented to the Company for approval prior to being submitted for payment by the Funder.
16. SUBSEQUENT EVENTS
On April 21, 2026, the Company announced it had entered into a binding Share Sale Agreement (“SSA”) with Riedel Resources Ltd (“Riedel”) (ASX:RIE) to sell its Cosmo and Mt Venn Projects (the “Projects”) in exchange for a combination of equity consideration and the payment of certain project-related expenses (the “Transaction”).
Pursuant to the SSA, Riedel will acquire Sarama’s interest in the Projects through the acquisition of a 100% interest in Sarama’s wholly-owned subsidiary, Yikarri Resources Pty Ltd for consideration comprising equity in Riedel and payment of certain project-related expenses on Sarama’s behalf as follows:
- issuance of 150 million shares in Riedel to Sarama (or its nominee);
- issuance of 100 million performance rights in Riedel to Sarama (or its nominee) across four tranches vesting upon the achievement of certain exploration, mineral resource and share price milestones; and
- payment of project-related costs that are incurred by Sarama, capped at A$300,000 (excluding GST).
Completion is targeted for June 2026, subject to the satisfaction of certain conditions precedent, including (amongst others) Riedel shareholder approval.
25